Table 3. Antimicrobial susceptibility testing results of 252 CRKP isolates based on local clinical laboratories (%, n).

Antimicrobial agents	S [n]	I [n]	R [n]
Ertapenem	0 [0]	0 [0]	100 [252]
Meropenem	2.4 [6]	4.4 [11]	93.3 [235]
Imipenem	0 [0]	0.8 [2]	99.2 [250]
Ceftazidime	1.2 [3]	0 [0]	98.8 [249]
Ceftriaxone	0 [0]	0 [0]	100 [252]
Cefotaxime	0.8 [2]	0 [0]	99.2 [250]
Aztreonam	2.8 [7]	0 [0]	97.2 [245]
Cefepime	2.4 [6]	0.8 [2]	96.8 [244]
Piperacillin/Tazobactam	3.6 [9]	0.4 [1]	96.0 [242]
Ciprofloxacin	6.4 [16]	1.6 [4]	92.1 [232]
Levofloxacin	8.7 [22]	2.8 [7]	88.5 [223]
Gentamicin	11.5 [29]	4.0 [10]	84.5 [252]
Tobramycin	7.5 [19]	2.4 [6]	90.1 [227]
Amikacin	36.9 [93]	4.4 [11]	58.7 [105]
Trimethoprim/sulfamethoxazole	23.0 [58]	3.2 [8]	73.8 [186]
Tigecycline	92.5 [233]	3.2 [8]	4.4 [11]
Colistin	99.6 [251]	0 [0]	0.4 [1]

CRKP, carbapenem-resistant Klebsiella pneumoniae.